GI
INBX icon

GAMMA Investing’s Inhibrx INBX Stock Holding History

GAMMA Investing’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.1K Buy
181
+14
+8% +$1.4K ﹤0.01% 2926
2026
Q1 		$11.2K Buy
167
+2
+1% +$148 ﹤0.01% 3009
2025
Q4 		$13K Buy
165
+26
+19% +$1.77K ﹤0.01% 2848
2025
Q3 		$4.68K Sell
139
-16
-10% -$394 ﹤0.01% 3207
2025
Q2 		$2.21K Sell
155
-335
-68% -$4.33K ﹤0.01% 3377
2025
Q1 		$6.86K Buy
490
+421
+610% +$5.72K ﹤0.01% 2934
2024
Q4 		$1.06K Sell
69
-76
-52% -$1.16K ﹤0.01% 3409
2024
Q3 		$2.27K Buy
145
+143
+7,150% +$2.01K ﹤0.01% 3031
2024
Q2 		$28 Buy
+2
New +$31 ﹤0.01% 3436

Other funds holding INBX

EWM
Empirical Wealth Management Seattle, Washington $6.85B AUM 30.02% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
DAS
Dynamic Advisor Solutions Phoenix, Arizona $3.53B AUM 22.61% 1-Year Est. Return
NS
NBC Securities Birmingham, Alabama $1.48B AUM 31.07% 1-Year Est. Return
PCM
Presidio Capital Management San Diego, California $400M AUM 22.73% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
TM
Torren Management San Diego, California $197M AUM
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return

GAMMA Investing's INBX Position: Q2 2026 in Review

GAMMA Investing increased its Inhibrx (INBX) stake by 8.4% in Q2 2026, buying an estimated $1.4K and bringing the position to 181 shares worth $17.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2926.

GAMMA Investing first reported a position in INBX in Q2 2024 and has held it in 9 quarters since. 11 funds tracked by Wall St. Rank hold INBX as of Q2 2026.

  • GAMMA Investing held 181 shares of Inhibrx worth $17.1K as of Q2 2026.
  • GAMMA Investing bought 14 Inhibrx shares in Q2 2026, an estimated $1.4K.
  • Inhibrx made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #2926 holding.
  • GAMMA Investing first reported a position in Inhibrx in Q2 2024 and has held it in 9 quarters since.
  • 11 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.